Before revision: Another Morpholino-based drug golodirsen (also for Duchenne muscular dystrophy) was approved by FDA in December 2019.
After revision: Other Morpholino-based drugs golodirsen, viltolarsen, and casimersen (also for Duchenne muscular dystrophy) were approved by FDA in